Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-201474

Director acquired 6,032 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jerman Michael Allen Director 2026-04-29 Grant or award +6,032 $2.59 $15,623 15,621 D
Loading xslF345X06/ownership.xml…